WeVote

Bill

Bill

SB 31

AN ACT INCREASING THE BOND AUTHORIZATION FOR THE CONNECTICUT BIOSCIENCE INNOVATION FUND.

2026 Regular Session Introduced by Tony Hwang

Connecticut increases state bond authorization for bioscience innovation fund to boost biotech investment and economic development capacity.

CHG. REF., SEN. TO COMM. ON Finance, Revenue and Bonding
0
WeVote Research Nonpartisan
Bill Summary · SB 31

Legislative bill overview

SB 31 authorizes increased bonding (borrowing) for Connecticut's Bioscience Innovation Fund, a state program designed to support research, development, and commercialization of bioscience ventures. The bill expands the state's financial capacity to invest in biotech companies and research initiatives within Connecticut. The specific dollar amount of the increase is not detailed in the action history provided.

Why is this important

Bioscience and biotechnology are high-growth industries with significant potential for job creation and economic development. Connecticut's bonding authorization directly affects how much capital the state can deploy to attract and nurture biotech companies, potentially influencing the state's competitiveness in this sector. These investments can drive innovation, attract talent, and generate tax revenue, though they also represent public debt obligations.

Potential points of contention

  • Fiscal responsibility concerns: Increased state bonding adds to Connecticut's debt burden; critics may question whether this represents prudent fiscal management or overextension during uncertain economic times
  • Accountability and returns on investment: Questions about whether previous biotech fund investments have yielded promised economic returns and job growth, and whether expanded funding addresses documented shortcomings
  • Geographic equity: Debate over whether bioscience investments benefit all regions of Connecticut equally or concentrate benefits in certain areas with existing biotech clusters

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.